HBT-708

· Shenyang Sunshine Pharmaceutical Co., LTD.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HBT-708, covering 2025-07-11 to 2025-07-11. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of HBT-708 for Patients With Advanced Solid Tumors [Phase 1]